Showing 761-770 of 3390 results for "".
Guselkumab in PsA: Exploring Patient-Reported Outcomes in Real-World Settings
https://practicaldermatology.com/topics/psoriasis/guselkumab-in-psa-exploring-patient-reported-outcomes-in-real-world-settings/20226/Philip Mease, MD, shares new real-world data showing that psoriatic arthritis patients who take Tremfya (guselkumab) report meaningful improvements in pain, physical function, and fatigue through six months.Recognizing Dermatologic Emergencies in Kids
https://practicaldermatology.com/conferences/scale-2023/recognizing-dermatologic-emergencies-in-kids/20198/Infections including congenital infections, syphilis, or HSV are the No. 1 cause of pediatric skin emergencies. Infantile hemangiomas in the airway can affect breathing and also require fast and early treatment, explains Thy Huynh, MD.Evidence-based Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/evidence-based-skincare/18491/Evidence-based skincare is the foundation of a 360-degree cosmetic rejuvenation plan, says Shannon Humphrey, MD. Hear her number 1 recommendation for all aesthetic patients.Tips for Treating Children
https://practicaldermatology.com/conferences/noah-worcester/tips-for-treating-children/57066/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, discusses her two Alfred L. Weiner lectures on pediatric dermatology from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.The Latest Skin Cancer Developments
https://practicaldermatology.com/conferences/noah-worcester/the-latest-skin-cancer-developments/57062/Darrell S. Rigel, MD, discusses his presentation, “Skin Cancer Update 2026 – What You Need to Know for Your Practice,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Using GEP Test Results to Manage Patients
https://practicaldermatology.com/programs/practical-dermatology-updates-in-skin-cancer/using-gep-test-results-to-manage-patients/35603/Jason M. Rizzo, MD, describes how gene expression profile (GEP) testing works and how the results can be used to manage patients from a dermatologist's perspective.Epidermal Inclusion Cysts: Dr. Goldman
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/epidermal-inclusion-cysts-dr-goldman/32687/Mitchel Goldman, MD, who took part in the "Neuromodulator and Dermal Filler" panel at Maui Derm 2025, talks about a new treatment for epidermal inclusion cysts, involving sclerotherapy medication."You've Just Been Served": Dr. Goldberg
https://practicaldermatology.com/programs/practical-dermatology/youve-just-been-served-dr-goldberg/32691/David Goldberg, MD, JD, discusses lessening the likelihood of lawsuits and winning lawsuits involving negligence, employees, and teledermatology, which he covered during his session, "You've Just Been Served," at Maui Derm 2025.Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/series/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.